Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:41:27.729Z.
Calculation as of: 2026-10-06T16:41:27.729Z.
Quote observation: 2026-10-06T16:39:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a536da8eae666eb645f8b33c150b74020e4e9b3ff535c5becd935f4d76daa57
EARNINGS YIELD
N/A
Market Cap
$16.76M
Earnings Yield
N/A
TTM Avg
16.05%
3Y Avg
16.05%
5Y Avg
16.05%
Market Cap
$16.40M
Earnings Yield
N/A
TTM Avg
119.21%
3Y Avg
119.21%
5Y Avg
80.35%
Market Cap
$15.83M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.64M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | N/A | 16.05% | 16.05% | 16.05% |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | N/A | 119.21% | 119.21% | 80.35% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | N/A | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.19M | N/A | 0.00% | 5.85% | 5.85% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 4.38% | 3.50% | 25.86% |
| PAVmed Inc. (PAVM)vs › | $17.27M | N/A | 194.82% | 194.82% | 194.82% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.82M | N/A | 2.31% | 2.31% | 2.31% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | N/A | 0.79% | 0.79% | 0.82% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
